NCT06688708

Brief Summary

  • Quantitative data will be presented with median (mean) and standard deviation (SD).
  • Qualitative data will be presented with numbers and percentages.
  • An independent t-test will be used to compare the independent outcomes.
  • A paired t-test will be used to compare the dependent outcomes.
  • A repeated-measures ANCOVA will be used for between group comparisons.
  • A repeated-measures ANOVA will be used for within-group comparison.
  • MANCOVA will be used for analyzing the covariates' effect on the relationship between the independent grouping variables and the continuous dependent variables.
  • Cohen's d will be used to determine the effect sizes.
  • Ethical Consideration (1) All participants were provided with detailed project information prior to participation in the research project.
  • Using the novel VFO may lead to efficient treatment for neurorehabilitation in DPN.
  • The investigators hope that this low-cost VFO can offer advantages such as affordability, widespread use, and home-based applications.
  • The benefits of using the novel VFO that can improve tactile sensation on the plantar surface of the foot in diabetic peripheral neuropathy.
  • Employing the novel VFO can reduce VPT.
  • Using the novel VFO can help prevent diabetic foot ulceration (DFU), lessen a risk of DFU recurrence, and avoid lower limb amputation.
  • Applying the novel VFO may help restore and prolong tactile sensation.
  • Using the novel VFO may aid in slowing DPN deterioration and decreasing peripheral nervous system impairment.
  • Utilizing the VFO may help improve quality of life for DPN people.
  • Payment was provided for those participants who attend throughout the study.
  • All participants received a custom-made foot orthosis after completing the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 8, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 14, 2024

Completed
Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

6 months

First QC Date

November 8, 2024

Last Update Submit

November 16, 2024

Conditions

Keywords

Diabetic Peripheral NeuropathyNoiseOrthosisStochastic ResonanceTactileVibration

Outcome Measures

Primary Outcomes (1)

  • Vibration Perception Threshold (VPT)

    Vibration perception threshold (VPT) is the lowest vibrational intensity required to perceive a vibration stimulus, and VPT is known to be impaired at an early stage in various neuropathies. VPT is critical in detecting diabetic peripheral neuropathy early; as a result, VPT is relevant to the risk of diabetic foot ulceration (DFU). Thus, VPT is an effective predictor of the risk of DFU and it could be used to target DFU for early detection and treatment.

    Immediate assessment after finish intervention

Study Arms (2)

Use vibrating foot orthosis with tactile stimulation

EXPERIMENTAL

32 participants were assigned to use a vibrating foot orthosis (VFO) with tactile stimulation (using the VFO combined with a random 0-100 Hz square wave pulse stimulus with pseudorandom white noise via a stochastic resonance approach) at home for 30 days. Participants had to conduct intervention for 60 minutes a day. 90% VPT of each participant was chosen as the subthreshold stimulation level for tactile stimulation. Posttests were given by three consecutive appointments on the 1st day, the 15th day, and the 30th day. Participants had to meet a prosthetist and orthotist (PO) at the experimental site on the three consecutive appointments for posttest evaluation. After completing this intervention, participants were followed up the VPT level by evaluation every 7 days.

Device: Using vibrating foot orthosis with tactile stimulation

Use vibrating foot orthosis without tactile stimulation

SHAM COMPARATOR

32 participants were assigned to use the VFO without tactile stimulation (using the VFO with only vibration 100 Hz frequency ) at home for 30 days. Participants were blinded. Even though there was no tactile stimulation, the device still performed vibration. Posttests were given by three consecutive appointments on the 1st day, the 15th day, and the 30th day. Participants had to meet a PO at the experimental site on the three consecutive appointments for posttest evaluation. Noted, there was no follow-up after completing this intervention.

Device: Using vibrating foot orthosis without tactile stimulation

Interventions

Stimulating tactile sensation by using vibrating foot orthosis in conjunction with a random 0-100 Hz square wave pulse stimulus and pseudorandom white noise via a stochastic resonance approach.

Also known as: Using vibrating foot orthosis in conjunction with a random 0-100 Hz square wave pulse stimulus and pseudorandom white noise via a stochastic resonance approach
Use vibrating foot orthosis with tactile stimulation

Stimulating tactile sensation by using vibrating foot orthosis with only vibration 100 Hz freqency.

Also known as: Using vibrating foot orthosis with only vibration 100 Hz freqency
Use vibrating foot orthosis without tactile stimulation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 diabetes mellitus and peripheral neuropathy diagnosis
  • Absence of foot problems such as ulcers, calluses, skin problems, etc.
  • No muscle weakness
  • Stability in neurological and vital signs
  • Adequate cognitive and language skills to follow instructions
  • Ability to sense vibration
  • Ability to sit for at least 60 minutes

You may not qualify if:

  • Musculoskeletal problem that makes it difficult to use vibrating foot orthosis, such as severe pain or joint contracture in any foot joints
  • Mental disorders
  • Hypersensitivity to material substances in vibrating foot orthosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Srinakharinwirot University

Ongkharak, Changwat Nakhon Nayok, 26120, Thailand

Location

Study Officials

  • Natapatchakrid Thimabut, Ph.D.

    Srinakharinwirot University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Allocation concealment Participants and Investigators were blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Intervention 1: Use vibrating foot orthosis with tactile stimulation Intervention 2: Use vibrating foot orthosis without tactile stimulation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 8, 2024

First Posted

November 14, 2024

Study Start

June 12, 2023

Primary Completion

November 30, 2023

Study Completion

December 29, 2023

Last Updated

November 20, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

IPD and documents will be available for sharing 1 year and after publication for a period of 2 years. Access to the IPD and documents will be open on the IPDShare website with registration. The information will be freely available and can be used for any purpose. There will not be any review process or no Data Use Agreement will be necessary.

Shared Documents
STUDY PROTOCOL
Time Frame
IPD and documents will be available for sharing 1 year and after publication for a period of 2 years.

Locations